Alzamend Neuro, Inc.
ALZN
Revenue
0.00
0.000.00%
-Assets
1.67M
▲1.04M▲164.39%
3 Months ChangeLiabilities
2.88M
▼-343.60k▼-10.65%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001214659-24-017549
2024-10-03
Form 8-K
ID: 0001214659-24-017141
2024-09-11
Form 10-Q
ID: 0001214659-24-016346
2024-07-31
Form 8-K
ID: 0001214659-24-013382
2024-07-12
Form 8-K
ID: 0001214659-24-012340
2024-07-08
Form 8-K
ID: 0001214659-24-012079
2024-05-22
Form 8-K
ID: 0001214659-24-009785
2024-05-15
Form 8-K
ID: 0001214659-24-009345
2024-05-13
Form 8-K
ID: 0001214659-24-008914
2024-05-09
Form 8-K
ID: 0001214659-24-008706